Sonic Healthcare Competitors
Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
---|---|---|---|---|---|---|---|---|
PFE | Pfizer | Outperform |
2
|
$27.77 | $32.87 | 9.83% | 6 | $157.25B |
BMY | Bristol-Myers Squibb | Hold |
2
|
$44.04 | $58.15 | 22.62% | 10 | $89.27B |
IQV | IQVIA Holdings | Outperform |
15
|
$229.14 | $267.27 | 20.01% | 19 | $41.75B |
IDXX | IDEXX Laboratories | Outperform |
14
|
$483.68 | $583.92 | 20.95% | 0 | $39.95B |
ICLR | ICON Public | Buy |
16
|
$314.54 | $306.07 | 14.45% | 1 | $26.01B |
SGSN | SGS | Hold |
18
|
CHF82.38 | CHF86.34 | 9.25% | 7 | CHF15.59B |
LH | Laboratory Corp of America Hol... | Outperform |
11
|
$201.50 | $241.28 | 20.10% | 9 | $16.99B |
DGX | Quest Diagnostics | Outperform |
10
|
$136.94 | $141.17 | 5.89% | 8 | $15.21B |
BVI | Bureau Veritas | Outperform |
18
|
27.98€ | 26.96€ | 10.79% | 12 | 12.44€B |
ERF | Eurofins Scientific | Hold |
18
|
56.72€ | 0.00€ | 5.78% | 5 | 11.11€B |
CRL | Charles River Laboratories Int... | Outperform |
16
|
$236.30 | $229.97 | 17.12% | 11 | $11.76B |
NTRA | Natera | Buy |
7
|
$97.15 | $74.41 | 6.54% | 8 | $11.35B |
EXAS | Exact Sciences | Buy |
8
|
$61.41 | $90.32 | 45.27% | 7 | $10.91B |
ITRK | Intertek Group | Outperform |
18
|
£50.10 | £44.87 | 5.39% | 14 | £7.97B |
RHC | Ramsay Health Care | Hold |
18
|
$51.60 | $56.32 | 8.55% | 13 | $11.80B |
SYNH | Syneos Health | - |
16
|
$42.98 | $43.00 | -100.00% | 0 | $2.64B |
MCOV B | Medicover AB (publ) | Outperform |
16
|
kr188.40 | kr18.54 | -91.07% | 0 | kr26.19B |
GH | Guardant Health | Buy |
6
|
$18.82 | $43.00 | 133.79% | 2 | $2.30B |
NEO | NeoGenomics | Outperform |
8
|
$15.57 | $20.09 | 22.03% | 9 | $1.95B |
EVT | Evotec | Outperform |
14
|
9.54€ | 37.33€ | 78.20% | 4 | 1.73€B |
MYGN | Myriad Genetics | Hold |
6
|
$19.78 | $22.08 | 26.39% | 8 | $1.79B |
APPS | Applus Services | Outperform |
15
|
12.68€ | 10.92€ | -5.76% | 3 | 1.63€B |
VCYT | Veracyte | Outperform |
11
|
$21.03 | $32.17 | 54.54% | 4 | $1.61B |
OPK | OPKO Health | Outperform |
8
|
$1.01 | $6.70 | 296.04% | 0 | $1.18B |
4544 | H.U. Group Holdings | Outperform |
17
|
¥2.69k | ¥0.00 | -7.05% | 0 | ¥164.15B |
HLS | Healius | Underperform |
17
|
$1.29 | $1.84 | -3.10% | 1 | $874.95M |
CDNA | CareDx, Inc | Outperform |
9
|
$10.48 | $11.80 | 24.05% | 1 | $505.52M |
VRT | Virtus Health | - |
16
|
$8.10 | $7.35 | -100.00% | 0 | $705.23M |
CAJ | Capitol Health | Outperform |
12
|
$0.24 | $0.27 | 12.50% | 1 | $245.05M |
CRDF | Cardiff Oncology | Buy |
10
|
$3.31 | $8.37 | 156.80% | 1 | $154.70M |
ONT | 1300SMILES | - |
18
|
$8.12 | $8.00 | -100.00% | 0 | $192.51M |
AXDX | Accelerate Diagnostics | Buy |
8
|
$0.90 | $5.00 | -100.00% | 1 | $21.49M |
IDXG | Interpace Biosciences | - |
0
|
$1.06 | $11.00 | -100.00% | 0 | $4.54M |
NVTA | Invitae | - |
4
|
$0.00 | $0.71 | 0.00% | 8 | $3.18M |
ROSG.Q | Rosetta Genomics | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.00M |